Skip to Main Content (Press Enter)

Logo UNILINK
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture

UNI-FIND
Logo UNILINK

|

UNI-FIND

unilink.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  1. Pubblicazioni

DRUG SAFETY

Rivista
Codice:
E053978
ISSN:
0114-5916
  • Dati Generali

Dati Generali

Pubblicazioni (14)

  • ascendente
  • decrescente
ADHD Medication Use and Psychiatric Comorbidity, Trauma and Mortality in Children and Young Adults: A Cohort Study from Quebec, Canada
Abstract
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals
Articolo
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health
Articolo
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health
Articolo
Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases
Articolo
Explicit criteria for potentially inappropriate medications to reduce the risk of adverse drug reactions in elderly people: from Beers to STOPP/START criteria
Articolo
Frailty and safety: the example of diabetes
Articolo
Geriatric conditions and the risk of adverse drug reactions in older adults: a review
Articolo
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance
Articolo
Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database
Articolo
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database
Articolo
Risk of Mortality Associated with Potentially Inappropriate Medication Use Including Opioids in Older Adults
Articolo
Risk of Psychotic Disorders Among Patients with Medical Cannabis Authorization: A Longitudinal Cohort Study
Abstract
What Is the Safety Profile of Cannabis-Based Medications? Analysis of the Post-Marketing Signals from the FDA Adverse Event Reporting System
Abstract
No Results Found
  • «
  • ‹
  • {pageNumber}
  • ›
  • »
{startItem} - {endItem} di {itemsNumber}
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.6.0.0